Robot Therapists Need Rules

Interactions with artificial intelligence (AI) will become an increasingly common aspect of our lives. A team at the Technical University of Munich (TUM) has now completed the first study of how "embodied AI" can help treat mental illness. Their conclusion: Important ethical questions of this technology remain unanswered. There is urgent need for action on the part of governments, professional associations and researchers.

Robot dolls that teach autistic children to communicate better, computer-generated avatars that help patients cope with hallucinations, and virtual chats offering support with depression: Numerous initiatives using embodied AI for improving mental health already exist. These applications are referred to as embodied because they involve interactions between individuals and an artificial agent, resulting in entirely new dynamics.

The use of AI in psychotherapy is not new as such. Back in the 1960s, the first chatbots created the illusion of a psychotherapy session. In reality, however, this was little more than a gimmick. With today's advanced algorithms and higher computing power, much more is possible. "The algorithms behind these new applications have been trained with enormous data sets and can produce genuine therapeutic statements," explains Alena Buyx, Professor of Ethics in Medicine and Health Technologies at TUM. With Dr. Amelia Fiske and Peter Henningsen, Professor of Psychosomatic Medicine and psychotherapy, she has conducted the first systematic survey of embodied AI applications for mental health and drawn conclusions on the related opportunities and challenges.

Access to treatment for more people

The new applications have enormous potential. They can make treatment accessible to more people because they are not limited to specific times or locations. In addition, some patients find it easier to interact with AI than with a human being. But there are risks, too. "AI methods cannot and must not be used as a cheaper substitute for treatment by human doctors," says Amelia Fiske.

"Although embodied AI has arrived in the clinical world, there are still very few recommendations from medical associations on how to deal with this issue. Urgent action is needed, however, if the benefits of these technologies are to be exploited while avoiding disadvantages and ensuring that reasonable checks are in place. Young doctors should also be exposed to this topic while still at medical school," says Peter Henningsen, who is the dean of the TUM School of Medicine.

Ethical rules for artificial intelligence still lacking

At present, there are increased efforts to draw up guidelines for AI, including the Ethics Guidelines for Trustworthy AI just issued by the EU. However, Buyx, Fiske and Henningsen also see an urgent need to regulate the use of AI in specialized fields. "Therapeutic AI applications are medical products for which we need appropriate approval processes and ethical guidelines," says Alena Buyx. "For example, if the programs can recognize whether patients are having suicidal thoughts, then they must follow clear warning protocols, just like therapists do, in case of serious concerns."

In addition, intensive study is needed into the social effects of embodied AI. "We have very little information on how we as human beings are affected by contact with therapeutic AI," says Alena Buyx. "For example, through contact with a robot, a child with a disorder on the autism spectrum might only learn how to interact better with robots - but not with people."

Fiske A, Henningsen P, Buyx A.
Your Robot Therapist Will See You Now: Ethical Implications of Embodied Artificial Intelligence in Psychiatry, Psychology, and Psychotherapy.
J Med Internet Res 2019;21(5):e13216. doi: 10.2196/13216.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...